Carbidopa impurity F

CAS : 1458640-32-8

Ref. 3D-FH177492

Informations sur le produit

• Nom: Carbidopa impurity F
• Synonymes: (αS)-α-Hydrazinyl-3,4-dihydroxy-α-methylbenzenepropanoic acid ethyl esterCarbidopa EP impurity F

Description

Carbidopa is an impurity of the drug L-DOPA, which is used as a treatment for Parkinson's disease. Carbidopa is a prodrug that is converted to L-DOPA by decarboxylase, an enzyme in the body. The conversion process can be inhibited by the presence of carbidopa impurity F (CIF), which binds to carboxamides and forms a stable complex with them. This prevents CIF from binding to decarboxylase and blocking its ability to convert carbidopa into L-DOPA. CIF has been shown to have anti-parkinsonian effects by reducing the severity of symptoms associated with Parkinson's disease such as muscular rigidity and tremors.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 254.28 g/mol
• Formule: C₁₂H₁₈N₂O₄
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder